Verici Dx plc

Verici Dx plc

VRCDF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.64M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Verici Dx plcVerici Dx plc-0.5--256%-0.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.64 Million
Enterprise Value$3.00 Million
Earnings per Share$-0.01
Beta1.17
Outstanding Shares1,547,790,450

Return

Return on Equity-256.28%ROE
Return on Assets-179.70%
Return on Invested Capital-242.05%

Valuation & Multiples

P/E Ratio-0.53P/E Ratio
PEG-0.81PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.6
Enterprise Value to EBIT-0.19
Enterprise Value to Net Income-1
Total Debt to Enterprise0.26
Debt to Equity0.14Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 14, 2026
EPS
-$0.00
Reported
Revenue
$1.77 M
Reported

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Verici Dx plc

19 employees
CEO: Sara jane Barrington

Verici Dx plc is an immuno-diagnostics developer primarily dedicated to innovations within the kidney transplantation field. It creates both prognostic (predictive) and diagnostic (identifying current conditions) assays specifically desi...